None
Quote | Dthera Sciences (OTCMKTS:DTHR)
Last: | $0.0015 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0015 |
Close: | $0.0015 |
High: | $0.0015 |
Low: | $0.0015 |
Volume: | 1,305 |
Last Trade Date Time: | 08/12/2021 04:40:35 am |
News | Dthera Sciences (OTCMKTS:DTHR)
NEW YORK , June 5, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lists of downgrades from its respective OTCQX® and OTCQB® markets and Caveat Emptor Desig...
SAN DIEGO, CA / ACCESSWIRE / April 2, 2019 / Dthera™ Sciences (OTCQB: DTHR) a leading digital therapeutic company specializing in neurodegenerative diseases, today announced that its Board of Directors has initiated a process to pursue a range of potential strategic transactions to en...
Message Board Posts | Dthera Sciences (OTCMKTS:DTHR)
Subject | By | Source | When |
---|---|---|---|
200,000 unrestricted shares, 100k @ DTC. Only | Werbe | investorshub | 06/05/2019 9:52:31 PM |
$DTHR: effective Sept. 25,2018 a one for 20 | Renee | investorshub | 09/24/2018 4:26:48 PM |
DTHR .42 news out FDA breakthrough designation: | lukin4winners | investorshub | 08/23/2018 2:22:00 PM |
I've said this before and I'll say it | cryptosujiwooji | investorshub | 04/05/2018 1:35:21 PM |
Anybody know if they have any type of | Frankieenzo | investorshub | 04/03/2018 8:44:36 PM |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK , June 5, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lists of downgrades from its respective OTCQX® and OTCQB® markets and Caveat Emptor Desig...
SAN DIEGO, CA / ACCESSWIRE / April 2, 2019 / Dthera™ Sciences (OTCQB: DTHR) a leading digital therapeutic company specializing in neurodegenerative diseases, today announced that its Board of Directors has initiated a process to pursue a range of potential strategic transactions to en...
SAN DIEGO, CA / ACCESSWIRE / February 25, 2019 / Dthera ™ Sciences (OTCQB: DTHR), a leading digital therapeutic company specialized in neurodegenerative diseases, is pleased to announce that it has entered into an exclusivity agreement with a company headquartered in Japan for develo...